LifeVantage CEO Steve Fife and CMO Julie Boyster on the Science of Nutrigenomics:  “Take it to Make it” episode artwork

EPISODE · Aug 4, 2025 · 27 MIN

LifeVantage CEO Steve Fife and CMO Julie Boyster on the Science of Nutrigenomics: “Take it to Make it”

from WTR Small-Cap Spotlight · host Water Tower Research

Send us Fan MailIn this episode of our WTR Small Cap Spotlight, we sat down with LifeVantage (NASDAQ: LFVN ) CEO Steve Fife and CMO Julie Boyster to drill down on the science of nutrigenomics, which is the study of how nutrients impact our genes, and how LifeVantage’s proprietary formulations of naturally found ingredients work together to activate genes and help improve overall health and wellbeing.  Recent clinical studies further demonstrate the efficacy of the company’s new patent-pending MindBody GLP-1 System, and the company discusses additional synergistic benefits from combining MindBody with the company’s flagship Nrf2 Synergizer.   

Episode metadata supplied by the publisher feed · Published Aug 4, 2025

Embed this episode

NOW PLAYING

LifeVantage CEO Steve Fife and CMO Julie Boyster on the Science of Nutrigenomics: “Take it to Make it”

0:00 27:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of WTR Small-Cap Spotlight?

This episode is 27 minutes long.

When was this WTR Small-Cap Spotlight episode published?

This episode was published on August 4, 2025.

Can I download this WTR Small-Cap Spotlight episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!